Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Christiane Marti has worked on the following 44 EPO patent applications which have been published in the last five years:

EP12700094

INDOLE COMPOUNDS OR ANALOGUES THEREOF USEFUL FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD)

IPC classification:
A61K 31/403, A61K 31/407, A61K 31/416, A61P 27/02, C07D 401/14, C07D 403/12, C07D 403/14, C07D 405/14, C07D 409/14, C07D 417/12, C07D 417/14, C07D 471/04
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
The patent has been granted
EP12723241

SUSPENSION TYPE TOPICAL FORMULATIONS COMPRISING CYCLIC DEPSIPEPTIDE

IPC classification:
A61K 9/00, A61K 9/06, A61K 38/15, A61K 47/06, A61K 47/14, A61P 17/00
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP12727933

PROCESSES FOR THE MANUFACTURE OF MACROCYCLIC DEPSIPEPTIDES AND NEW INTERMEDIATES

IPC classification:
C07K 11/02
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP12766749

COMPOUNDS AND COMPOSITIONS AS PDGFR KINASE INHIBITORS

IPC classification:
A61K 31/437, A61P 37/00, C07D 471/04
Applicant:
Novartis Pharmaceuticals UK Limited
Agent:
Christiane Marti, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12762445

COMPOUNDS AND COMPOSITIONS AS C-KIT KINASE INHIBITORS

IPC classification:
A61K 31/437, A61P 11/06, C07D 471/04
Agent:
Christiane Marti, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12756884

COMPOUNDS AND COMPOSITIONS AS C-KIT KINASE INHIBITORS

IPC classification:
A61K 31/437, A61P 3/00, A61P 11/00, A61P 17/00, A61P 29/00, C07D 471/04
Agent:
Christiane Marti, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12791859

QUINAZOLINE DERIVATIVES AS PI3K MODULATORS

IPC classification:
A61K 31/517, A61P 11/00, A61P 29/00, A61P 35/00, A61P 37/00, C07D 239/74, C07D 401/04, C07D 401/14, C07D 403/04, C07D 403/14, C07D 413/14, C07D 487/08
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12738616

SOLID FORMS AND SALTS OF TETRAHYDRO-PYRIDO-PYRIMIDINE DERIVATIVES

IPC classification:
A61K 31/517, A61P 29/00, C07D 471/04
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
APPLICATION WITHDRAWN
EP12818825

USE OF INHIBITORS OF THE ACTIVITY OR FUNCTION OF PI3K

IPC classification:
A61K 31/517, A61K 31/519, A61P 33/00
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP12823036

DIHYDRO-BENZO-OXAZINE AND DIHYDRO-PYRIDO-OXAZINE DERIVATIVES

IPC classification:
A61K 31/536, A61K 31/5365, A61P 19/02, A61P 33/06, A61P 35/00, A61P 37/08, C07D 413/14, C07D 498/04
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP12823037

QUINOLINE DERIVATIVES

IPC classification:
A61K 31/498, A61P 35/00, C07D 401/12, C07D 401/14, C07D 413/12
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12743023

TETRAHYDROPYRIDO-PYRIDINE AND TETRAHYDROPYRIDO-PYRIMIDINE COMPOUNDS AND USE THEREOF AS C5A RECEPTOR MODULATORS

IPC classification:
A61K 31/4375, A61K 31/519, A61P 27/02, A61P 37/00, C07D 471/04
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
PATENT GRANTED
EP13729096

COMPLEMENT PATHWAY MODULATORS AND USES THEREOF

IPC classification:
A61P 27/02, A61P 37/00, C07D 403/06, C07D 413/06, C07D 417/06
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
PATENT GRANTED
EP13729573

COMPOUNDS AND COMPOSITIONS FOR MODULATING EGFR ACTIVITY

IPC classification:
A61K 31/395, C07D 235/30, C07D 401/12
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP13733200

COMPLEMENT PATHWAY MODULATORS AND USES THEREOF

IPC classification:
A61K 31/517, A61P 27/00, A61P 37/00, C07D 239/95, C07D 401/12, C07D 401/14, C07D 403/04, C07D 403/12, C07D 403/14, C07D 405/12, C07D 409/12, C07D 413/14
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13765775

PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS

IPC classification:
A61K 31/4439, A61K 31/444, A61K 31/4745, A61K 31/497, A61P 3/00, A61P 9/00, A61P 11/00, A61P 19/00, A61P 27/00, A61P 37/00, C07D 401/14, C07D 403/14, C07D 417/14, C07D 471/04
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13762560

PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS

IPC classification:
A61K 31/416, A61K 31/4162, A61K 31/506, A61P 3/00, A61P 9/00, A61P 11/00, A61P 19/00, A61P 27/00, A61P 37/00, C07D 403/06, C07D 403/14, C07D 471/04, C07F 7/08
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP13762561

PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS

IPC classification:
A61K 31/416, A61K 31/4162, A61K 31/427, A61K 31/506, A61P 3/00, A61P 9/00, A61P 11/00, A61P 19/00, A61P 27/00, A61P 37/00, C07D 403/06, C07D 403/14, C07D 417/04, C07D 417/14
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP13762559

PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS

IPC classification:
A61K 31/404, A61K 31/416, A61P 3/00, A61P 9/00, A61P 11/00, A61P 19/00, A61P 27/00, A61P 37/00, C07D 403/06, C07D 403/12
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP13752768

1,4-DISUBSTITUTED PYRIDAZINE ANALOGS AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS

IPC classification:
A61K 31/501, A61P 21/00, C07D 401/12, C07D 401/14, C07D 403/14, C07D 405/14, C07D 409/14, C07D 413/14, C07D 417/14, C07D 471/04, C07D 471/08, C07D 471/14, C07D 487/04, C07D 487/10
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP13785621

2'-ETHYNYL NUCLEOSIDE DERIVATIVES FOR TREATMENT OF VIRAL INFECTIONS

IPC classification:
A61P 31/14, C07H 19/067
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP13795867

OXAZOLIDIN-2-ONE-PYRIMIDINE DERIVATIVES

IPC classification:
A61K 31/506, A61P 35/00, C07D 413/14, C07D 417/14
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
The patent has been granted
EP13824177

SOLID FORM OF DIHYDRO-PYRIDO-OXAZINE DERIVATIVE

IPC classification:
A61K 31/5365, A61P 29/00, C07D 498/04
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
The patent has been granted
EP14719470

2-(1H-INDOL-4-YLMETHYL)-3H-IMIDAZO[4,5-B]PYRIDINE-6-CARBONITRILE DERIVATIVES AS COMPLEMENT FACTOR B INHIBITORS USEFUL FOR THE TREATMENT OF OPHTHALMIC DISEASES

IPC classification:
A61K 31/437, A61P 27/02, C07D 471/04
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
PATENT GRANTED
EP14728655

PYRIMIDIN-4-YL)OXY)-1H-INDOLE-1-CARBOXAMIDE DERIVATIVES AND USE THEREOF

IPC classification:
A61K 31/506, C07D 403/14
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP14744744

PIPERIDINYL INDOLE DERIVATIVES AND THEIR USE AS COMPLEMENT FACTOR B INHIBITORS

IPC classification:
A61K 31/454, A61K 31/4545, A61K 31/5377, A61P 27/00, A61P 37/00, C07D 401/06, C07D 401/14, C07D 403/06, C07D 413/14, C07D 417/14
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP14747273

AMINOMETHYL-BIARYL DERIVATIVES AS COMPLEMENT FACTOR D INHIBITORS AND USES THEREOF

IPC classification:
C07C 229/06, C07C 233/75, C07C 311/21, C07D 213/81
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP14803001

COMPOSITIONS AND METHODS FOR MODULATING FARNESOID X RECEPTORS

IPC classification:
A61K 31/4162, C07D 471/04, C07D 491/052
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP14802972

2-BENZYL-BENZIMIDAZOLE COMPLEMENT FACTOR B INHIBITORS AND USES THEREOF

IPC classification:
A61K 31/4184, A61P 27/02, C07D 235/12, C07D 235/14
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15714147

MONOBACTAM ORGANIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS

IPC classification:
A61K 31/427, A61K 31/437, A61K 31/4439, A61K 31/454, A61K 31/496, A61P 31/04, C07D 417/14, C07D 487/04
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP14726416

PYRAZINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS

IPC classification:
A61K 31/497, A61P 17/00, A61P 35/00, A61P 37/00, C07D 401/04, C07D 403/04, C07D 403/14, C07D 409/04, C07D 417/04
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP14726415

AMINO PYRAZINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS

IPC classification:
C07D 401/04, C07D 401/14, C07D 403/04, C07D 403/14, C07D 405/14, C07D 409/04, C07D 413/04, C07D 417/04, C07D 417/14
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15721435

ISOXAZOLINE HYDROXAMIC ACID DERIVATIVES AS LPXC INHIBITORS

IPC classification:
A61K 31/42, A61P 31/04, C07D 261/04, C07D 413/04, C07D 413/10
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP14726414

AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS

IPC classification:
A61K 31/4439, A61P 11/06, C07D 213/73, C07D 401/04, C07D 401/14, C07D 413/04, C07D 413/14, C07D 417/04, C07D 491/107
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15724409

COMPOUNDS AND COMPOSITIONS AS TOLL-LIKE RECEPTOR 7 AGONISTS

IPC classification:
A61K 31/519, A61P 17/00, A61P 29/00, A61P 31/12, A61P 35/00, A61P 37/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15727098

COMPOUNDS AND COMPOSITIONS AS TOLL-LIKE RECEPTOR 7 AGONISTS

IPC classification:
A61K 31/519, A61P 29/00, A61P 31/12, A61P 35/00, A61P 37/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15727792

METHODS FOR MAKING CONJUGATES FROM DISULFIDE-CONTAINING PROTEINS

IPC classification:
A61K 47/50
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15732439

AURISTATIN DERIVATIVES AND CONJUGATES THEREOF

IPC classification:
C07K 5/02, A61K 47/50
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15742104

THIOPHEN-2-YL-PYRIDIN-2-YL-1H-PYRAZOLE-4-CARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS

IPC classification:
A61K 31/4545, A61P 27/06, C07D 409/14
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15742105

CYCLOHEXEN-1-YL-PYRIDIN-2-YL-1H-PYRAZOLE-4-CARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS

IPC classification:
A61K 31/445, A61P 27/06, C07D 401/12, C07D 401/14
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15742103

INDANE AND INDOLINE DERIVATIVES AND THE USE THEREOF AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS

IPC classification:
A61K 31/445, A61P 27/06, C07D 401/10, C07D 401/12, C07D 401/14
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15750132

QUINOLONE DERIVATIVES AS ANTIBACTERIALS

IPC classification:
A61K 31/4704, A61P 31/04, C07D 215/22, C07D 215/38
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP17157570

OXAZOLIDIN-2-ONE-PYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF SKIN FIBROSIS, SCLERODERMA, HYPERTROPHIC SCARS OR KELOIDS

IPC classification:
A61K 31/506, A61P 17/00
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
The application has been published
EP15798567

AMATOXIN DERIVATIVES AND CONJUGATES THEREOF AS INHIBITORS OF RNA POLYMERASE

IPC classification:
A61K 38/12, A61P 35/00, C07K 7/64
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
Request for examination was made

Please Sign in to use this feature